__2.jpg)
Levosartan (S-amlodipine+Valsartan)
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Payment Terms
- T/T
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- antihypertensives, s-amlodipine, valsartan, arb
- Category
- Pharmaceuticals
AHN-GOOK PHARMACEUTICAL CO.,LTD.
- Membership
- VIP
- Recent Visit
- Nov 11, 2024
- Country / Year Established
-
South Korea
/
1959
- Business type
- Manufacturer
- Verified Certificate
-
16
| Product name | Levosartan (S-amlodipine+Valsartan) | Certification | - |
|---|---|---|---|
| Category | Pharmaceuticals | Ingredients | - |
| Keyword | antihypertensives , s-amlodipine , valsartan , arb | Unit Size | - |
| Brand name | - | Unit Weigh | - |
| origin | South Korea | Stock | - |
| Supply type | - | HS code | 3004909900 |
Product Information
Levosartan (S-amlodipine + Valsartan 2.5/80mg, 2.5/160mg, 5/160mg)
- The First S-amlodipine
- No. 1 ARB Valsartan
- Fixed Combination of Antihypertensives
<S-Amlodipine>
- The 1st CCB
- Chiral propuct of Amlodipine -> S-amlodipine is 1,000 times more effective, safe
- S-amlodipine is responsable for antihypertensive and antianginal actions.
<S-amlodipine + Valsartan>
- The 1st combination drug of S-amlodipine besylate and Valsartan in Korea
- Strong BP lowering effect by fixed combination of CCB-ARB
- Kidney protective effect
Levosartan (S-amlodipine + Valsartan 2.5/80mg, 2.5/160mg, 5/160mg)
- The First S-amlodipine
- No. 1 ARB Valsartan
- Fixed Combination of Antihypertensives
<S-Amlodipine>
- The 1st CCB
- Chiral propuct of Amlodipine -> S-amlodipine is 1,000 times more effective, safe
- S-amlodipine is responsable for antihypertensive and antianginal actions.
<S-amlodipine + Valsartan>
- The 1st combination drug of S-amlodipine besylate and Valsartan in Korea
- Strong BP lowering effect by fixed combination of CCB-ARB
- Kidney protective effect
Levosartan (S-amlodipine + Valsartan 2.5/80mg, 2.5/160mg, 5/160mg)
- The First S-amlodipine
- No. 1 ARB Valsartan
- Fixed Combination of Antihypertensives
<S-Amlodipine>
- The 1st CCB
- Chiral propuct of Amlodipine -> S-amlodipine is 1,000 times more effective, safe
- S-amlodipine is responsable for antihypertensive and antianginal actions.
<S-amlodipine + Valsartan>
- The 1st combination drug of S-amlodipine besylate and Valsartan in Korea
- Strong BP lowering effect by fixed combination of CCB-ARB
- Kidney protective effect
B2B Trade
| Price (FOB) | Negotiable | transportation | - |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | T/T | Shipping time | Negotiable |
- President
- Eo Junseon
- Address
- yeongdeungpo-gu,613 siheung-daero, Yeongdeungpo-gu, Seoul, Korea
- Product Category
- Pharmaceuticals
- Year Established
- 1959
- No. of Total Employees
- 101-500
- Company introduction
-
Established in 1959, Ahngook has been developed to one of leading pharmaceutical corporation in Korea.
Starting from first oral form of eye-nutrient, Tobicom-S, Ahngook developmed numerous promising New drugs and Incrementally modified drugs.
Ahngook is especially strong to cardiovascular, respiratory, urology and other niche areas.
Ahnook is aggresively attending several internationl exhibitions to introduce our major products in the galobal market with the aim of becoimg a top global company.
So now, we're expanding our business network to Japan, Vietnam, Malaysia, Iran and some region of Africa and Latin countries.
- Main Markets
-
Iran
Japan
Mexico
Philippines
Viet Nam
- Main Product
_2.jpg "Anycough Cap_ _Theobromine 300mg__1")
